Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
Latest Features
LATEST ARTICLES
Improving Black Representation in Oncology: ‘Be the Change’
Only 3% of medical oncologists in the United States are Black.
Responses to COVID-19 Vaccines in Cancer Patients: Impact of Tumor and Treatment Type
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Experts Disagree on COVID-19 Vaccine Mandates for Health Care Providers
Experts outline benefits and detriments of COVID-19 vaccine mandates.
Lymphoma Patients Show Continued Cognitive Decline After Chemotherapy
Lymphoma patients displayed cognitive decline 6 months after chemotherapy, both by objective assessment and self-report.
Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
Language in Patient Records Can Convey More Than Medical History
The language in a patient’s medical record can convey information not only about the patient’s condition but about the attitude of the clinician writing the report.
New Therapies on the Horizon for Elderly or Frail Patients With Head and Neck Cancer
A nanoparticle-radiotherapy regimen and a chemoimmunotherapy regimen both appear safe and effective for this population.
Radiomics ‘Not Ready for Prime Time’ in Endometrial Cancer
More research is needed before radiomics can be used in clinical practice, according to researchers.
Current and Emerging Therapies for Relapsed and Refractory Multiple Myeloma
Experts review approved therapies and treatments still under investigation.
Updated Screening Guidelines for 5 Cancer Types
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
Metformin Fails to Show Benefit in Non-Small Cell Lung Cancer Trials
Metformin did not improve progression-free or overall survival in either study.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist
The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.
Study Reveals Genetic Features of Rhabdomyosarcoma That May Improve Risk Stratification
Integrating molecular profiling into current clinical stratification could improve outcomes in rhabdomyosarcoma, according to researchers.
Blood-Based Test May Establish a ‘New Paradigm’ for Cancer Screening
The test can accurately detect cancer and predict where it is located, according to researchers.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...